Sheila Keating
Sheila Keating
Vice President of Immunology at Gigagen, Inc.; Associate Adjunct Professor UCSF; Affiliate
Adresse e-mail validée de gigagen.com
Titre
Citée par
Citée par
Année
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane, AA Pathan, CR Sander, SM Keating, SC Gilbert, K Huygen, ...
Nature medicine 10 (11), 1240-1244, 2004
7242004
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane, AA Pathan, CR Sander, SM Keating, SC Gilbert, K Huygen, ...
Nature medicine 10 (11), 1240-1244, 2004
7242004
Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases
TJ Henrich, E Hanhauser, FM Marty, MN Sirignano, S Keating, TH Lee, ...
Annals of internal medicine 161 (5), 319-327, 2014
3882014
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
DP Webster, S Dunachie, JM Vuola, T Berthoud, S Keating, SM Laidlaw, ...
Proceedings of the National Academy of Sciences 102 (13), 4836-4841, 2005
3122005
Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation
TJ Henrich, Z Hu, JZ Li, G Sciaranghella, MP Busch, SM Keating, ...
The Journal of infectious diseases 207 (11), 1694-1702, 2013
2952013
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient
SA Yukl, E Boritz, M Busch, C Bentsen, TW Chun, D Douek, E Eisele, ...
PLoS Pathog 9 (5), e1003347, 2013
2802013
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults
VS Moorthy, EB Imoukhuede, P Milligan, K Bojang, S Keating, P Kaye, ...
PLoS Med 1 (2), e33, 2004
2042004
Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys
NL Letvin, SS Rao, DC Montefiori, MS Seaman, Y Sun, SY Lim, WW Yeh, ...
Science translational medicine 3 (81), 81ra36-81ra36, 2011
1942011
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria …
SJ Dunachie, M Walther, JE Epstein, S Keating, T Berthoud, L Andrews, ...
Infection and immunity 74 (10), 5933-5942, 2006
1882006
Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers
JM Vuola, S Keating, DP Webster, T Berthoud, S Dunachie, SC Gilbert, ...
The Journal of Immunology 174 (1), 449-455, 2005
1832005
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
P Bejon, J Mwacharo, O Kai, T Mwangi, P Milligan, S Todryk, S Keating, ...
PLOS Clin Trial 1 (6), e29, 2006
1672006
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against …
SM Keating, P Bejon, T Berthoud, JM Vuola, S Todryk, DP Webster, ...
The Journal of Immunology 175 (9), 5675-5680, 2005
1512005
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men
VS Moorthy, EB Imoukhuede, S Keating, M Pinder, D Webster, ...
The Journal of infectious diseases 189 (12), 2213-2219, 2004
1382004
The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of US women
SM Keating, ET Golub, M Nowicki, M Young, K Anastos, H Crystal, ...
AIDS (London, England) 25 (15), 1823, 2011
1372011
Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosis
SC Gilbert, VS Moorthy, L Andrews, AA Pathan, SJ McConkey, JM Vuola, ...
Vaccine 24 (21), 4554-4561, 2006
1362006
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
R Kassanjee, CD Pilcher, SM Keating, SN Facente, E McKinney, MA Price, ...
AIDS (London, England) 28 (16), 2439, 2014
1322014
Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys
J Liu, BF Keele, H Li, S Keating, PJ Norris, A Carville, KG Mansfield, ...
Journal of virology 84 (19), 10406-10412, 2010
1242010
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS, S/AS02A and MVA-CS
SJ Dunachie, M Walther, JM Vuola, DP Webster, SM Keating, T Berthoud, ...
Vaccine 24 (15), 2850-2859, 2006
1112006
The induction and persistence of T cell IFN-γ responses after vaccination or natural exposure is suppressed by Plasmodium falciparum
P Bejon, J Mwacharo, O Kai, S Todryk, S Keating, B Lowe, T Lang, ...
The Journal of Immunology 179 (6), 4193-4201, 2007
1002007
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720
M Walther, S Dunachie, S Keating, T Berthoud, A Schmidt, C Maier, ...
Vaccine 23 (7), 857-864, 2005
962005
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20